Back
CRISPR Therapeutics AG Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
46
CRSP
CRISPR Therapeutics AG
Last Price:
$56.69
Seasonality Move:
16.15%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 25.3% based on the past 9 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $56.68. The Score for CRSP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 25.3% based on the past 9 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
46
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
78.48
52-Week Low:
30.04
Prediction Charts
Market Cap:
5.4B
Price in USD:
56.68
Volume:
1.4M
Beta:
2.05
Technical Analysis
SMA50:
60.61
SMA100:
59.26
SMA200:
50.79
52-Wk Change:
24.85%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 56.68 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-24 | 50.40 | 51.25 | 51.51 | 49.31 |
| Nov-25 | 50.89 | 53.57 | 53.89 | 49.96 |
| Nov-26 | 53.63 | 53.30 | 53.78 | 52.30 |
| Nov-28 | 52.84 | 53.47 | 54.00 | 51.50 |
| Dec-1 | 52.30 | 52.17 | 53.46 | 51.00 |
| Dec-2 | 52.43 | 51.58 | 53.03 | 51.20 |
| Dec-3 | 51.49 | 55.99 | 56.01 | 51.16 |
| Dec-4 | 55.99 | 58.18 | 59.77 | 54.93 |
| Dec-5 | 58.18 | 56.88 | 58.76 | 56.01 |
| Dec-8 | 58.12 | 57.36 | 58.76 | 56.68 |
| Dec-9 | 57.00 | 57.04 | 58.00 | 55.65 |
| Dec-10 | 56.34 | 57.59 | 58.47 | 54.41 |
| Dec-11 | 56.85 | 58.09 | 59.25 | 56.61 |
| Dec-12 | 57.95 | 56.68 | 58.50 | 55.52 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.